Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanwha Systems (272210) – Decision on Disposal of Shares and Investment Certificates in Other Corporations / 2026-03-06

Posted on March 6, 2026August 10, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Systems (272210) – Decision on Disposal of Shares and Investment Certificates in Other Corporations / 2026-03-06

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanwha Systems is securing liquidity by selling approximately 13.92 million shares of its affiliate Hanwha Ocean (valued at approximately KRW 1.7T) and entering into a Price Return Swap (PRS) contract.

📊 [Key Disclosure Contents & Summary of Key Figures]

  1. Company Outline of Target Entity
  • Company Name: Hanwha Ocean Co., Ltd. (South Korea)
  • Relationship with Hanwha Systems: Affiliate
  • Core Business: Transportation equipment and components
  • Total Outstanding Shares: 306,413,394 shares
  1. Details of Disposal
  • Number of Shares to Dispose: 13,923,011 shares
  • Disposal Amount: KRW 1,699,999,643,100 (KRW 1.7T)
  • Ratio to Total Assets: 29.70% (Based on Hanwha Systems consolidated total assets of KRW 5,724,010,115,718 as of FY2024)
  • Ratio to Total Equity: 70.35% (Based on Hanwha Systems consolidated total equity of KRW 2,416,416,895,456 as of FY2024)
  1. Post-Disposal Shares Held and Equity Stake
  • Shares Held Post-Disposal: 21,527,899 shares
  • Equity Stake Post-Disposal: 7.03%
  1. Purpose and Transaction Terms
  • Purpose of Disposal: Securing liquidity and investment resources for strategic investments
  • Scheduled Disposal Date: April 06, 2026 (Based on transaction execution date)
  • Settlement Date: April 08, 2026 (2 business days after the scheduled disposal date)
  • Transaction Type and Payment Method: Off-hours block trade, Cash payment
  • Counterparties: The Sarah 1st Co., Ltd. and 6 other entities (The Sarah 1st, Felix OS 1st, Felix OS 2nd, KISS ON 10th, KISS Prime 4th, N2 Glory 1st, N2 Glory 2nd)
  1. Planned Price Return Swap (PRS) Contract Details
  • Underlying Asset: 13,923,011 common shares of Hanwha Ocean Co., Ltd.
  • Reference Price: KRW 122,100 (Closing price as of March 05, 2026)
  • Settlement Structure: Difference between the sales reference amount and settlement reference amount settled upon buyer’s sale
  • Contract Period: 1 year
  • Note: Quantities, amounts, and percentages are estimated based on the closing price prior to the Board resolution and will be finalized via a correction disclosure using the closing price of the business day prior to the scheduled disposal date.
  1. Financial Summary of Target Company (Hanwha Ocean, FY2024 Consolidated Basis)
  • Total Assets: KRW 17,843,809,161,295 (KRW 17.84T)
  • Total Liabilities: KRW 12,980,459,270,570 (KRW 12.98T)
  • Total Equity: KRW 4,863,349,890,725 (KRW 4.86T) / Capital Stock: KRW 1,537,066,970,000 (KRW 1.54T)
  • Revenue: KRW 10,776,004,933,627 (KRW 10.78T)
  • Net Income: KRW 528,212,898,147 (KRW 528.2B)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Final Correction Disclosure Regarding Finalized Transaction Terms and PRS Contract Details

The number of shares to be disposed of, total disposal amount, remaining stake, and PRS contract conditions stated in this disclosure are estimates calculated based on the closing price of the business day prior to the Board resolution, and are subject to change based on the closing price of the business day prior to the scheduled disposal date. Verifying how these adjusted trade quantities and settlement reference terms are finalized in the upcoming corrected disclosure is essential to understanding the final terms of the transaction. These finalized details can be checked in future corrected disclosures and periodic reports.

📢 Disclaimer & Source Notice

Source: This content was newly structured and created based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities lie with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Hanmi Semiconductor (042700) – Decision on Convening of General Shareholders Meeting / 2026-03-05
Next Post: [Disclosure] Hanwha Systems (272210) – (Correction) Resolution on Convening of General Meeting of Shareholders / 2026-03-06

Related Posts

[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-06-26 Disclosures
[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-04-24 Disclosures
[Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-25 Disclosures
[Disclosure] Hanwha Systems (272210) – Decision on Paid-in Capital Increase / 2025-11-24 Disclosures
[Disclosure] HPSP (403870) – Additional Listing (Exercise of Stock Options) / 2025-12-17 Semiconductors
[Disclosure] Hanwha Ocean (042660) – (Correction) Other Management Matters / 2025-04-25 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations (Correction) / 2026-08-10August 10, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Convening General Meeting of Shareholders / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date for Shareholder Register Closure / 2026-08-07August 7, 2026
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme